Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease

17 Feb 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Natural product bioactivities and synthesis
Share to NF-κB Signaling Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22366375
DOI: 10.1016/j.vph.2012.02.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relevance of new drug discovery to reduce NF-κB activation in cardiovascular diseasePMID 22366375Read ↗

NF-Κb, A Potential Therapeutic Target, In Cardiovascular DiseasesSemantic proximity Read ↗

Transcription Factor NF-κB: An Update on Intervention StrategiesSemantic proximity Read ↗

Small Molecules with Big Impacts on Cardiovascular DiseasesSemantic proximity Read ↗

Small Molecule NF-κB Pathway Inhibitors in ClinicSemantic proximity Read ↗

Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling PathwaySemantic proximity Read ↗

Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challengesSemantic proximity Read ↗

Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint diseaseSemantic proximity Read ↗

NF-&#954;B in Human Disease: Current Inhibitors and Prospects for De Novo Structure Based Design of InhibitorsSemantic proximity Read ↗

Exploring the positive and negative consequences of NF-kappaB inhibition for the treatment of human disease.Semantic proximity Read ↗

Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)Semantic proximity Read ↗

The therapeutic potential of BRD4 in cardiovascular diseaseSemantic proximity Read ↗

FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological interventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.